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Summary
Objective: To analyze the distribution of leptin, adiponectin and resistin between paired serum and synovial ﬂuid (SF) samples of patients with
osteoarthritis (OA) and to determine the potential sources of these adipokines in the joint. The active free form of leptin was also examined by
evaluating the level of the soluble leptin receptor (sOb-R).
Methods: Levels of adipokines and sOb-R were measured by a sandwich enzyme-linked immunosorbent assay in serum and SF collected
from OA patients. The levels of adipokines were also determined in conditioned media from cultured joint tissues (synovium, infrapatellar
fat pad, meniscus, osteophyte, cartilage and bone).
Results: The adipokines exhibited different patterns of distribution between the joint and the circulating compartment. Serum levels of resistin
and adiponectin exceeded those in the paired SF. Conversely, leptin SF concentrations were similar or higher than those measured in serum
counterparts. Leptin and adiponectin in SF may derive from each joint tissue examined, whereas resistin was not detected in conditioned me-
dia of cultured explants. Synovium and infrapatellar fat pad were the major sources of adipokines, but osteophytes released also large
amounts of leptin. The sOb-R deﬁciency found in SF further increased the difference in the bioactive leptin levels between serum and SF.
A gender-speciﬁc difference was observed with women exhibiting the highest level of free leptin in the joint.
Conclusion: These data demonstrated that adipokines serum levels are not predictive values for SF determination. The joint cavity is a special
space where each adipokine undergoes speciﬁc regulatory pathways, strengthening the hypothesis that adipokines may have local effects in
the joint and may account for the high prevalence of OA in women.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Obesity is a chronic multi-factorial disease with increasing
prevalence in most industrialized countries. It is associated
with several other diseases such as diabetes mellitus, cor-
onary artery disease, hypertension, and several forms of
cancer. Obesity represents also a potent risk factor for the
development and the progression of osteoarthritis
(OA)1e3. The pathology of OA involves the whole joint in
a degenerative process that includes focal and progressive
articular cartilage loss with concomitant changes in the un-
derlying bone and development of osteophytes. The over-
load effect may explain most of the increased risk for OA
of the knee and hip among overweight persons. However,
the risk factor for developing OA in non-weight-bearing
joints, such as hands, was also shown to be associated
with body mass index (BMI)4,5. In addition, if weight loss
may prevent the onset of OA6, Toda et al. found that the
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2006.690loss of body fat is more closely related to symptomatic ben-
eﬁt than is the loss of body weight7. Taken together, these
ﬁndings suggest that adipose factors may provide a meta-
bolic link between obesity and OA. The potential role of ad-
ipose-derived proteins in OA is emphasized by the ability of
the infrapatellar fat pad, which is an intra-articular tissue, to
produce cytokines8.
Adipose tissue expresses and secretes a large number of
proteins that often share functional and structural properties
of cytokines, and are therefore classiﬁed as adipokines9.
These include leptin, resistin and adiponectin. In humans,
circulating levels of both leptin and resistin are positively
correlated with the BMI and fat mass10e13, while adiponec-
tin plasma concentration is decreased in obese individ-
uals13,14. Leptin serves as a negative feedback signal for
the central nervous system to inhibit food intake and stimu-
late energy expenditure15e17. Leptin exhibits also peripheral
functions including the regulation of lipid metabolism18, in-
sulin secretion15, reproductive functions19, angiogenesis20,
and bone development21. Adiponectin increases insulin
sensitivity by reducing circulating fatty acid concentration
and triglyceride level in the liver and muscle22,23. Resistin
is another adipose-derived hormone regulating insulin sen-
sitivity seemingly opposite to adiponectin24.
Leptin, adiponectin and resistin have been detected in
the synovial ﬂuid (SF) obtained from patients with OA25,26.
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levels of resistin and of systemic markers of inﬂammation26.
In experimental models, leptin may display pro- or anti-
inﬂammatory effects in the joint depending on the immune
response27e29. In humans, Bokarewa et al. suggested
that intra-articular leptin may attenuate the erosive process
in the joints during the course of rheumatoid arthritis30. In
a previous study, we demonstrated that leptin expression
was up-regulated in both osteophytes and cartilage ob-
tained from patients with OA, especially in areas of matrix
depletion, ﬁbrillations, and chondrocytes clusters25. Leptin
exhibited biological activity on chondrocytes with stimula-
tion of anabolic functions through induction of growth fac-
tors synthesis25 and was shown to increase the effects of
pro-inﬂammatory cytokines31,32.
Consequently, local changes in adipokines concentra-
tions may have important pathophysiological implications
on cartilage homeostasis. To add further insights, we ex-
amined ﬁrst the distribution of leptin, adiponectin and re-
sistin between paired SF and serum samples obtained
from OA patients. Secondly, the soluble leptin receptor
(sOb-R) was also sought to evaluate in both the joint
space and the circulating compartment, the level of free
leptin, the presumed biologically active form of this adipo-
kine33,34. Finally, the possible articular sources of leptin,
adiponectin and resistin were identiﬁed by measuring their
concentrations in media of cultured joint tissues including
synovium, infrapatellar fat pad, meniscus, osteophyte, car-
tilage and bone. These investigations indicated that adipo-
kines exhibited different patterns of distribution between
circulating and joint compartments, suggesting that the re-
sulting imbalance between the synovial levels of adipo-
kines known to have opposite biological effects in
various diseases such as diabetes or inﬂammation, may
have further implications in the development and the pro-
gression of OA.
Patients and methods
PATIENTS AND SAMPLES
Thirty-ﬁve patients (20 women and 15 men, age 50e83
years [mean age 68.4 years]) who required total knee ar-
throplasty were included in the present study. Knee OA
was diagnosed from clinical and radiologic evaluation,
based on the American College of Rheumatology criteria35.
Because serum samples were not available from each pa-
tient, paired serum samples were obtained from 25 patients
only. Collected serum and SF samples were centrifuged at
4000 g for 15 min and stored at 80(C. Specimens of
synovium, infrapatellar fat pad, meniscus, osteophyte, carti-
lage and bone were collected from 12 OA patients. This hu-
man study was conducted in conformity with the declaration
of Helsinki principles, and written informed consent was ob-
tained from each participant.
EX VIVO CULTURE OF JOINT TISSUES
Synovium, infrapatellar fat pad, meniscus and osteophyte
were washed in phosphate buffered saline (PBS) and then
carefully dissected into small pieces (50e150 mg). One ex-
plant of each tissue was placed in each well of a 24-well
plate. Disks of cartilage and bone (50e100 mg) were cut
with a biopsy punch (6 mm) and two pieces were placed
into each well of a 48-well plate. Explants in triplicate
were ﬁrst precultured for 2 days at 37(C in a humidiﬁedatmosphere of 5% CO2 in Dulbecco’s Modiﬁed Eagle Me-
dium/Nut Mix F12 (DMEM/Ham’s F12 medium) supple-
mented with L-glutamine (2 mM), gentamycin (50 mg/ml),
and amphotericin B (0.25 mg/ml). The tissue specimens
were thereafter incubated in fresh medium and conditioned
media were harvested on day 2 and stored at 20(C.
ASSAYS
The concentrations of leptin, resistin and adiponectin in
SF and serum samples and in conditioned media of cul-
tured explants, and the levels of sOb-R in biological ﬂuids
were determined in duplicate by a sandwich enzyme-linked
immunosorbent assay (ELISA) using commercially avail-
able kits. The leptin, resistin, and adiponectin ELISA kits
were purchased from R&D Systems (Lille, France) while
that for sOb-R was obtained from BioVendor (Heidelberg,
Germany). Dilution and spiking experiments were per-
formed to validate the use of commercially available ELISA
kits for SF samples. Samples were diluted as appropriate
and paired samples were assayed in the same run. Accord-
ing to the manufacturers, the detection limits for leptin,
resistin, adiponectin, and sOb-R assays were 7.8 pg/ml,
26 pg/ml, 250 pg/ml, and 800 pg/ml, respectively. The inter-
assay coefﬁcients of variation for the four assays were
4.4%, 8.4%, 7.8%, and 3.6%, respectively. Intraassay
coefﬁcients of variation were less than 5%.
STATISTICAL ANALYSIS
The results are shown as mean values (S.E.M.). The lep-
tin/sOb-R ratio was used as an index of free leptin, and
was determined after converting concentrations to mmol/
ml. Statistical analysis was conducted with StatView for
Windows, version 5.0 (SAS, Cary, NC). Differences be-
tween women and men were analyzed using the nonpara-
metric ManneWhitney U test. Comparisons of the levels
between matched pairs of SF and serum samples were
made by the nonparametric Wilcoxon signed rank test.
The analysis of statistical correlation was performed by
the Spearman test of rank correlation. A P value less than
0.05 was considered signiﬁcant for differences and
correlations.
Results
ADIPOKINES AND sOb-R DETERMINATION IN SF SAMPLES
OBTAINED FROM OA PATIENTS
SF samples obtained from 35 OA patients (20 women
and 15 men) were analyzed for leptin, adiponectin, resis-
tin, and sOb-R. There was no signiﬁcant difference
between the female and male patients with respect to
age or BMI (Table I).
The adipokines were detected in each SF tested with
concentrations ranging from 0.80 to 72.31 ng/ml for leptin
(mean [S.E.M.], 15.94 [2.42] ng/ml), from 0.62 to 7.01 mg/ml
for adiponectin (mean [S.E.M.], 2.32 [0.29] mg/ml), and from
1.62 to 26.41 ng/ml for resistin (mean [S.E.M.], 7.26
[1.21] ng/ml). When gender-speciﬁc differences in these
levels were examined, only SF level of leptin in the female
group was found to be signiﬁcantly higher than that in the
male group (Table I).
Beside leptin, sOb-R could be determined in each SF
sample. Mean [S.E.M.] level of the sOb-R was higher in
women compared with men, but the difference did not reach
statistical signiﬁcance (Table I).
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Similar analysis were performed with the paired samples
of serum and SF collected at the same time from 25 pa-
tients with OA (14 women and 11 men). Our study revealed
a signiﬁcant difference between the two body ﬂuid compart-
ments with higher concentrations of resistin, adiponectin
and sOb-R in serum samples than in the SF counterparts
(Table II). By contrast, leptin concentrations in SF exceeded
those in the paired serum, except for four patients (one
woman and three men). Consistently, mean [S.E.M.] leptin
level was signiﬁcantly higher in SF obtained from female
patients than that measured in paired serum specimens,
while mean [S.E.M.] leptin level was similar in both biological
ﬂuids collected from male patients (Table II). Interestingly,
the difference between SF and serum levels increased
when the molar ratio leptin/sOb-R was used as an index
of free leptin. As illustrated in Fig. 1, leptin in serum dis-
played a 1.5- and a 4.5-fold molar excess vs corresponding
sOb-R in both male and female groups, respectively. These
molar excess increased signiﬁcantly in SF for both male
and female OA patients (mean [S.E.M.], 6.22 [1.15] for men
and 13.10 [2.14] for women) due mainly to the low SF
sOb-R level in the joint space (Fig. 1). The free leptin level
was higher in women than in men, but the difference
reached statistical signiﬁcance in serum only (P¼ 0.0128
for serum and P¼ 0.0634 for SF).
The calculated Spearman’s rank correlation indicated
that SF levels of adipokines signiﬁcantly correlated with
the corresponding values in paired serum samples, except
for resistin in the female group (Table II). Adipokines
levels in both compartments correlated more closely in
the male group compared to the female group. A relation-
ship between SF and serum levels was also found when
Table I
Concentrations of adipokines (leptin, adiponectin and resistin) and
sOb-R in SF obtained from patients with OA
Female Male
n 20 15
Age (years) 71.05 (7.41) 65.80 (7.74)
BMI (kg/m2) 28.20 (4.28) 30.13 (5.09)
Leptin (ng/ml) 20.77 (3.61) 9.49 (2.14)*
Adiponectin (mg/ml) 2.34 (0.37) 2.31 (0.47)
Resistin (ng/ml) 8.47 (1.75) 5.73 (1.58)
sOb-R (ng/ml) 7.33 (1.15) 4.85 (1.00)
Age and BMI are shown as mean values (SD). Concentrations
values are expressed as mean values (S.E.M.). Comparisons be-
tween genders were performed using the ManneWhitney U test
and P< 0.05 was considered signiﬁcant (*).paired samples obtained from male OA patients were
analyzed for sOb-R (r¼ 0.75, P¼ 0.0339). However, we
failed to demonstrate any signiﬁcant correlation for female
patients.
PRODUCTION OF ADIPOKINES BY JOINT TISSUES OBTAINED
FROM OA PATIENTS
To determine whether adipokines found in the SF may
derive from articular tissues, we examined the production
of leptin, adiponectin and resistin by cultured explants ob-
tained from 12 patients. Specimens of synovium, infrapatel-
lar fat pad, meniscus, osteophyte, cartilage and bone were
cultured in serum-free medium for 48 h.
As illustrated in Fig. 2, each joint tissue studied including
cartilage released adiponectin and leptin. Conversely, the
conditioned media from ex vivo cultured specimens did
not contain detectable amount of resistin. The production
of leptin and adiponectin was quite variable depending on
the tissue and ranged from 0.54 to 22.05 pg/mg of tissue
for leptin and from 22.65 to 522.31 pg/mg of tissue for adi-
ponectin. Synovium and infrapatellar fat pad have been
shown to be the main sources of adipokines in the joint.
Surprisingly, osteophytes released larger amounts of leptin
than did synovium or infrapatellar fat pad, so that the leptin/
adiponectin ratio was high compared to the other articular
tissues [Fig. 2(c)].
Discussion
In order to better evaluate the local contribution of leptin,
and several other adipokines, to the changes associated
with OA, we explored the relation between SF and serum
levels of adipokines in human OA, and the potential biolog-
ical activity of leptin in the joint by determining the level of its
soluble receptor in SF. Besides, we identiﬁed the articular
sources of leptin, adiponectin and resistin.
Since females exhibited higher levels of serum leptin than
males36 and a larger predisposition toward OA1,37, OA pa-
tients were separated by gender. No signiﬁcant difference
between males and females was observed with respect to
age or BMI. Our data indicated that the three adipokines
are present in the SF of OA patients with concentrations fall-
ing within the range of values determined by Scha¨fﬂer et al.
for adiponectin and resistin26. Except for adiponectin, adipo-
kines concentrations were more elevated in SF from women
compared with men, especially for leptin. This gender-
speciﬁc difference cannot be only explained by the differ-
ence in serum level, since the SF/serum ratio was shown
to be different between men and women (data not shown).Table II
Levels of the adipokines (leptin, adiponectin and resistin) and sOb-R in paired samples of serum and SF from patients with OA: correlation
between serum and SF levels
Female (n¼ 14) Male (n¼ 11)
Serum SF r Serum SF r
Leptin (ng/ml) 14.39 (2.71) 17.57 (2.75)# 0.789 (P¼ 0.0044) 8.56 (2.66)* 9.73 (2.87)* 0.936 (P¼ 0.0031)
Adiponectin (mg/ml) 11.04 (1.62) 1.59 (0.25)# 0.559 (P¼ 0.0437) 8.68 (1.44) 2.23 (0.60)# 0.924 (P¼ 0.0056)
Resistin (ng/ml) 10.09 (0.98) 5.51 (1.45)# 0.077 (NS) 14.01 (1.69) 3.67 (0.59)# 0.816 (P¼ 0.0099)
sOb-R (ng/ml) 17.38 (3.79) 7.81 (1.11)# 0.483 (NS) 14.47 (4.43) 4.34 (1.27)# 0.750 (P¼ 0.0339)
For serum and SF levels, results are expressed as mean values (S.E.M.). Statistical signiﬁcance between matched pairs of SF and serum
was determined using the Wilcoxon rank test (#). Comparisons between genders were performed using the ManneWhitney U test (*). Cor-
relations between SF levels and serum levels were calculated by Spearman’s correlation analysis (r, correlation coefﬁcient with P value of
correlation). P< 0.05 was considered signiﬁcant. NS: not signiﬁcant (P 0.05).
693Osteoarthritis and Cartilage Vol. 14, No. 7When paired samples of SF and serum were examined,
the adipokines exhibited different patterns of distribution be-
tween the joint and the circulating compartment. Serum
levels of resistin and adiponectin exceeded those in the
paired SF. Leptin contrasted with the other adipokines in
that SF concentrations were higher than the serum counter-
parts in female patients, and were similar to serum corre-
sponding values in male patients. These ﬁndings provide
evidence for a speciﬁc local dysregulation of adipokines in
the OA joint space and suggest that circulating levels of adi-
pokines do not represent the situation in the joint.
Several works indicated that the soluble isoform of leptin
receptor may determine the biological activity of this adipo-
kine33,34. For the ﬁrst time, sOb-R has been detected in SF
obtained from patients with OA, but at a low level compared
to serum values. The lower SF level of sOb-R in the female
group compared to the male group, and the lack of any cor-
relation between SF and serum levels in female OA patients
suggest that sOb-R undergoes a speciﬁc regulation in fe-
male OA patients with either an increase of its expression
in joint tissues or a proteolytic cleavage of the membrane-
associated receptor, especially through metalloprotei-
nases38. The high level of leptin associated with a decline
in sOb-R level in the joint compartment led to a large rise
in the SF bioavailable leptin. The presence of high level of
bioactive leptin in the joint from OA patients may have path-
ophysiological implications, more especially as leptin was
shown to increase nitric oxide production in chondrocytes
stimulated with interleukin-132. This free radical is known
to interfere with chondrocytes functions resulting in loss of
cartilage matrix through induction of apoptosis, activation
of metalloproteinases or inhibition of proteoglycan and
type II collagen synthesis39. The elevated level of bioactive
free form of leptin in SF from female OA patients compared
to male patients strengthens the hypothesis that obesity
and female sex are both risk factors for OA that may be at-
tributable to local rather than systemic biosynthesis of this
adipokine37.
The high SF level of leptin compared to serum may be
due to the increased permeability of inﬂamed synovial
membrane40,41. However, the SF level of resistin was low
Fig. 1. Free leptin levels in paired samples of serum and SF ob-
tained from female and male patients with OA. The molar ratio lep-
tin/sOb-R was used as an index of free leptin. The Wilcoxon test
was used to analyze difference in free leptin levels between serum
and SF within the patient (#). The ManneWhitney U test was used
to test for statistically signiﬁcant gender-speciﬁc difference in both
body ﬂuid compartments (*). P< 0.05 was considered signiﬁcant.compared to the corresponding value in serum. Since
both adipokines have a similar molecular weight, the high
SF/serum ratio of leptin suggests a local production in the
joint. The present study indicated that various tissues ob-
tained from OA-affected joints synthesized leptin. Synovium
and infrapatellar fat pad, which has been recently found to
be a source of cytokines in the knee8, released large
amounts of leptin. However, osteophytes was shown to rep-
resent the major source of intra-articular leptin while adipo-
nectin production in osteophytes was similar to the other
joint tissues. These data are in agreement with our previous
study reporting a high level of expression of this adipokine
Fig. 2. Leptin (a) and adiponectin (b), and molar ratio leptin/adipo-
nectin (c) produced by various cultured joint tissues obtained from
12 patients with OA. Explants of synovium (S), infrapatellar fat
pad (FP), meniscus (M), osteophyte (O), cartilage (C) and bone
(B) were precultured in serum-free medium for 48 h. Subsequently,
the medium was changed and the release of adipokines was exam-
ined after a further 48 h incubation. Values are the mean of three
paired replications for adipokines release by explants from the
same individuals and the medians are indicated in (a) and (b).
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tin in the formation of these hypertrophic bone structures.
The present study revealed that the SF has low level of
adiponectin compared to the serum counterpart. The trans-
port of adiponectin across the synovial membrane barrier
may be limited by its molecular weight (28 kDa), even
more by its presence as two complexes in serum, as
a hexamer and a higher order complex of between 12
and 18 subunits42. In fact, adiponectin found in SF may de-
rive from joint tissues, mainly synovium and infrapatellar fat
pad. We demonstrated for the ﬁrst time that cartilage from
OA-affected joints released adiponectin suggesting that, in
addition to leptin, this adipokine may modulate chondrocyte
functions. An imbalance between the rate of its intra-articu-
lar production and catabolism may explain the intra-articular
deﬁciency of adiponectin. The weak correlation between SF
level of adiponectin and the corresponding value in paired
serum samples, especially in women, supports the view
that adiponectin undergoes speciﬁc metabolic pathways in
the joint.
As was shown for adiponectin, resistin was found in
larger amount in serum than in SF. In male OA patients,
there was a signiﬁcant correlation between resistin levels
in both compartments, indicating that the intra-articular re-
sistin derived mostly from the blood. The SF/serum ratio
of resistin levels was shown to be signiﬁcantly higher in
women than in men, and synovial resistin level failed to cor-
relate with serum level in female OA patients. Taken to-
gether, these ﬁndings suggest that resistin is also
produced locally in the joint from female OA patients. The
lack of any detection for resistin in conditioned media of cul-
tured explants may be due to a low sensitivity of the ELISA
kit. SF levels of leptin and resistin were in the same order of
magnitude while the minimum detectable dose of resistin
was 8-fold higher than that of leptin. The high levels of resis-
tin found in homogenized tissues of synovium and fat pad
from OA-affected joints (data not shown) suggest that the
experimental conditions used for ex vivo explants culture
may be not suitable for resistin synthesis.
In conclusion, leptin, adiponectin and resistin exhibited
different patterns of distribution between the synovial and
the blood compartments. Circulating levels of adipokines
do not represent the situation in the joint space, implying
that adipokines may have local effects on articular tissues.
Leptin contrasted with the other adipokines in that its level
in the joint ﬂuid exceeded that determined in serum, proba-
bly because of a local production. Additionally, the sOb-R
deﬁciency observed in the SF led to a marked rise in the
free form of leptin, increasing therefore the difference be-
tween serum and SF levels of the bioactive leptin. Resistin
and adiponectin were found in SF at lower concentrations
compared with the serum counterpart. Joint tissues includ-
ing cartilage released larger amounts of adiponectin than
leptin, indicating that adiponectin found in SF may result
from speciﬁc regulatory pathways in the joint space. The
present study showed that the excess of free leptin and
the adiponectin deﬁciency usually found in obesity is also
observed in OA-affected joints, and may account for the de-
velopment of OA. In addition, the differing local turnover of
adipokines between female and male OA patients may ex-
plain why the increased risk for OA of the knee among over-
weight persons is stronger in women than in men1,37. It
remains to determine whether these adipokines in SF are
not only markers of changes associated with OA, but are
also involved in the pathogenesis or perpetuation of the dis-
ease process. More especially, a better understanding of
the high level of leptin production in osteophytes mayprovide new insights on the role of this adipokine in the
structural and biochemical changes found in OA. Besides,
as the infrapatellar fat pad has been shown to be the pri-
mary source of adipokines in the joint, further investigations
are needed to characterize the contribution of this intra-
articular adipose tissue to joint destruction during OA.
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